Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Pancreatic Neoplasms 14Neoplasm Metastasis 2Cholangiocarcinoma 2Tumor of Exocrine Pancreas 1Resectable Pancreatic Carcinoma 1Peritoneal Neoplasms 1Pancreatitis, Chronic 1Pancreatitis 1Pancreatic Intraductal Neoplasms 1Pancreatic Adenocarcinoma 1Neoplasms 1Locally Advanced Pancreatic Cancer 1Kidney Failure, Chronic 1Gastroparesis 1Colonic Neoplasms 1Carcinoma, Acinar Cell 1Adenoma, Islet Cell 1

Interventions

Everolimus 9Temozolomide 7Sunitinib 7Specimen Handling 4Octreotide 4Magnetic Resonance Spectroscopy 4Fluorouracil 4Capecitabine 4lutetium Lu 177 dotatate 3Leucovorin 3sargramostim 2montanide ISA 51 2incomplete Freund's adjuvant 2cabozantinib 2Thalidomide 2Streptozocin 2Sorafenib 2Oxaliplatin 2Irinotecan 2Injections 2Endoscopic Ultrasound-Guided Fine Needle Aspiration 2Doxorubicin 2Cytoreduction Surgical Procedures 2Colony-Stimulating Factors 2Bevacizumab 2surufatinib 1sapanisertib 1recombinant interferon alpha 2b-like protein 1pentetreotide 1pasireotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenoma, Islet Cell × Pancreatectomy × Clear all
NCT02624154 2015-12-08

Pancreatic Neuroendocrine Tumor:Factor of Surgery Influencing Survival

First Affiliated Hospital, Sun Yat-Sen University

Unknown
2 enrolled

Adenoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡